ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1067 • 2013 ACR/ARHP Annual Meeting

    Incidence and Prevalence Of Systemic Lupus Erythematosus: A 2010 Nation-Wide Population-Based Study Using French National Administrative Databases

    Laurent Arnaud1, Jean-Paul Fagot2, Michel Païta2, Alexis Mathian3, Anne Fagot-Campagna2 and Zahir Amoura4, 1Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, 2Caisse Nationale d’Assurance Maladie des Travailleurs Salariés, Paris, France, 3Internal Medicine Dpt 2, Pitié-Salpêtrière Hospital, APHP, Paris, France, 4Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France

    Background/Purpose: To date, only a small number of studies have examined the epidemiology of systemic lupus erythematosus (SLE) on a nation-wide basis. These studies were…
  • Abstract Number: 1069 • 2013 ACR/ARHP Annual Meeting

    Racial Differences In Systemic Lupus Erythematosus Patients’ Treatment Preferences: A Two-Site Study

    Ernest R. Vina1, Tammy O. Utset2, Michael J. Hannon3, Nicole Roberts4, Christopher M. Masi5 and C. Kent Kwoh6, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh and VA Pittsburgh Healthcare System, Pittsburgh, PA, 2Rheumatology, University of Chicago Medical Center, Chicago, IL, 3Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 4Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Internal Medicine, NorthShore University Health System, Evanston, IL, 6School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Racial disparities in systemic lupus erythematosus (SLE) exist, with African-American (AA) patients experiencing higher lupus damage scores and disease activity than white (WH) patients. …
  • Abstract Number: 1070 • 2013 ACR/ARHP Annual Meeting

    Characteristics and Medication Use Patterns Among Belimumab Users In a Commercially Insured Population With Systemic Lupus Erythematosus

    Xuehua Ke1, Jeetvan Patel2, Hong Kan2, Debra F Eisenberg1 and Alan Oglesby2, 1HealthCore Inc, Wilmington, DE, 2GlaxoSmithKline, Research Triangle Park, NC

    Background/Purpose: Belimumab is a B lymphocyte stimulator-specific inhibitor approved for treatment of systemic lupus erythematosus (SLE). The purpose of the study was to describe medication…
  • Abstract Number: 1071 • 2013 ACR/ARHP Annual Meeting

    Prevalence Of Systemic Lupus Erythematosus and Lupus Nephritis In The United States: Analysis Of Commercial and Public Insurance Billing Data

    Kunal Gandhi1, Evo Alemao1, Hugh Kawabata1 and Jan L. Hillson2, 1Bristol-Myers Squibb, Princeton, NJ, 2Bristol-Myers Squibb, Seattle, WA

    Background/Purpose:  Prevalence estimates of Systemic Lupus Erythematosus (SLE) in the U.S. vary, with numbers ranging from 161,000 (Helmick, 2008) to 1.5 million (Lupus Foundation of…
  • Abstract Number: 1032 • 2013 ACR/ARHP Annual Meeting

    Shared Decision-Making In The Choice Of Biologic Medication: The Patient Perspective

    Susan C. Bolge1, Helen Eldridge2 and Michael P. Ingham1, 1Janssen Scientific Affairs, LLC, Horsham, PA, 2Janssen Services, LLC., Titusville, NJ

    Background/Purpose: There has been increasing focus on the importance of patients participating in the treatment decision-making process with their physicians.  Previous research has demonstrated that…
  • Abstract Number: 1033 • 2013 ACR/ARHP Annual Meeting

    Psychological status correlates of disease activity and sleep quality in patients with Ankylosing Spondylitis: A case-control study

    Mingcan Yang1, Yutong Jiang2, Zhiming Lin3, Zetao Liao4, Qiuxia Li4, Yanli Zhang1 and Jieruo Gu5, 1Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2Rheumatology, Third affiliated hospital of Sun Yat-sen University, Guangzhou, China, 3Rheumatology, third affiliated hospital of Sun Yat-sen Universtiy, Guangzhou, China, 4Rheumatology, The Affiliated Third Hospital of Sun Yat-san University, Rheumatology, Guangzhou, China, 5Medicine, Third Affiliated Hospital of Sun Yat-sen University, GuangZhou, China

    Background/Purpose: The objective of this study was to compare psychological status and sleep quality between the patients with AS patients and healthy controls, and to discover the correlation between anxiety, depression and sleep disturbances, to evaluate the associated factors of disease specific variables in AS patients and to detect independent factors contributing to psychological variables. Methods: A nationwide face-to-face epidemiological investigation was performed in multiple centers of China. The demographic data , clinical symptoms/signs and psychological assessment data including Zung self-rating anxiety scale (SAS), Zung self-rating depression scale (SDS) and the Pittsburgh Sleep Quality Index questionnaire (PSQI) were collected using questionnaires. Mann-Whitney U test and t test was used in independent groups for parametric variables, whereas the Spearman correlation analysis and multiple stepwise regression analysis were used to assess correlation between parametric variables.  Results: 683 AS patients by the revised New York criteria for AS and 697 age-, sex-, education-matched healthy controls were enrolled in the study.(1) Compared with healthy controls, AS patients suffered from more severe psychological disorders and sleep disturbance(P
  • Abstract Number: 1034 • 2013 ACR/ARHP Annual Meeting

    The Part Of Function (Health assessment Questionnaire) In The SF-6D and EQ-5D Utility Measures Varies Over Time In Early Arthritis (ESPOIR cohort): Questionable Validity Of Deriving Quality Adjusted Life Years From HAQ

    Cécile Gaujoux-Viala1, Anne-Christine Rat2, Kossar Hosseini3, Rene-Marc Flipo4, Francis Guillemin3 and Bruno Fautrel5, 1EA 2415, Montpellier I University, Nîmes University Hospital, Rheumatology Department, Nîmes, France, 2Université de Lorraine, Nancy, F-54000, France; Inserm, CIC-EC CIE6, Nancy, F-54000, France; CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, F-54000, France; CHU de Nancy, Rheumatology department, Nancy, France, 3CHU Nancy, Clinical Epidemiology and Evaluation, Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France, 4Rheumatology, University Hospital Lille, Lille, France, 5Paris 6 – Pierre et Marie Curie University; AP-HP, Rheumatology, Pitié-Salpêtrière Hospital, - GRC-UPMC 08 – EEMOIS, Paris, France

    Background/Purpose: There is growing emphasis on the cost-effectiveness of treating early arthritis (EA). As few studies directly record the utility measures needed for economic analyses,…
  • Abstract Number: 1035 • 2013 ACR/ARHP Annual Meeting

    Psoriatic Arthritis and Mortality – a Nationwide Study

    Thorvardur Jon Love1,2, Thor Aspelund3, Alexis Ogdie4, Joel M. Gelfand5, Hyon K. Choi6, Vilmundur Gudnason3 and Bjorn Gudbjornsson2, 1Landspitali University Hospital, Reykjavik, Iceland, 2Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 3The Icelandic Heart Association, Kopavogur, Iceland, 4Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 5University of Pennsylvania., Philadelphia, PA, 6Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Psoriatic arthritis is an inflammatory arthritis that causes significant morbidity. While a study from a single research clinic in Canada published in the 1990´s…
  • Abstract Number: 1036 • 2013 ACR/ARHP Annual Meeting

    The Independent Impact Of Depression On Incident Myocardial Infarction In Psoriatic Disease: A Population-Based Cohort Study

    Lindsay C Burns1,2, Jan P. Dutz1 and Hyon Choi3,4,5, 1Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, 2Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 5Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Psoriasis (PsC) and psoriatic arthritis (PsA) represent common, lifelong inflammatory diseases of the skin and joints (respectively) that are associated with substantial cardiovascular and…
  • Abstract Number: 1037 • 2013 ACR/ARHP Annual Meeting

    Incidence Of Malignancy In Patients With Rheumatoid Arthritis From a Japanese Large Observational Cohort (NinJa)

    Atsushi Hashimoto1, Noriyuki Chiba2, Jinju Nishino3, Toshihiro Matsui4 and Shigeto Tohma5, 1Department of Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan, 2Department of Rheumatology, Morioka National Hospital, NHO, Iwate, Japan, 3Nishino Clinic, Orthopedics and Rheumatology, Tokyo, Japan, 4Department of Rheumatology, Sagamihara Hospital, National Hospital Organization, Kanagawa, Japan, 5Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan

    Background/Purpose :Patients with rheumatoid arthritis (RA) die mainly of cardiovascular/cerebrovascular diseases, respiratory diseases, infections, or malignancies. In recent years, the ratio of infections and respiratory…
  • Abstract Number: 1038 • 2013 ACR/ARHP Annual Meeting

    Impact Of Biological Treatment On Overall Mortality and On Incidence Of Second Cancers In Arthritis Patients – A Follow-Up Study From The Danish Danbio Registry

    Lene Dreyer1, Lene Mellemkjær2, Inger Marie Jensen Hansen3 and Merete Lund Hetland4, 1Internal Medicine - Rheumatology Section, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark, 2Danish Cancer Society Research Center, Copenhagen, Denmark, 3Department of Reumatology, OUH Svendborg Hospital, Svendborg, Denmark, 4Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, The Danish Rheumatologic Database (DANBIO), Glostrup Hospital., Copenhagen, Denmark

    Background/Purpose: It is largely unknown whether it is safe to treat arthritis patients with a previous malignancy with biologics. Only a few studies have address…
  • Abstract Number: 1039 • 2013 ACR/ARHP Annual Meeting

    Risk Of High-Grade Cervical Dysplasia In Women With Systemic Inflammatory Diseases

    Seoyoung C. Kim1, Robert J. Glynn2, Edward Giovannucci3, Sonia Hernandez-diaz4, Jun Liu5, Sarah Feldman2, Elizabeth W. Karlson6, Sebastian Schneeweiss7 and Daniel H. Solomon8,9, 1Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Harvard School of Publich Health, Boston, MA, 4Harvard School of Public Health, Boston, MA, 5Division of Pharmaoepidemiology, Brigham and Women's Hospital, Boston, MA, 6Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 7Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, MA, 8Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, 9Division of Rheumatology, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Human papillomaviruses (HPV) are causes of high-grade cervical dysplasia and cervical cancer. Persistent HPV infection, the major risk factor for cervical cancer, is associated…
  • Abstract Number: 1040 • 2013 ACR/ARHP Annual Meeting

    Use Of TNF Inhibitors Is Associated With a Reduced Risk Of Diabetes In RA Patients

    Siri Lillegraven1, Jeffrey D. Greenberg2, George W. Reed3, Katherine C. Saunders3, Jeffrey R. Curtis4, Leslie R. Harrold5, Marc C. Hochberg6, Dimitrios A. Pappas7, Joel M. Kremer8 and Daniel H. Solomon9, 1Diakonhjemmet Hospital, Oslo, Norway, 2NYU Hospital for Joint Diseases, New York, NY, 3Corrona, LLC., Southborough, MA, 4Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5University of Massachusetts Medical School, Worcester, MA, 6Medicine, University of Maryland School of Medicine, Baltimore, MD, 7Department of Medicine, Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, NY, 8Center for Rheumatology, Albany Medical College, Albany, NY, 9Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA

    Background/Purpose: Inflammation may contribute to diabetes risk, and some studies indicate that certain DMARDs might be associated with a reduced risk of diabetes. Most studies…
  • Abstract Number: 1041 • 2013 ACR/ARHP Annual Meeting

    Non-Differential Reporting Of Myocardial Infarction To a National Observational Drug Safety Study Using Linked Data: Linkage Of The British Society For Rheumatology Biologics Register For Rheumatoid Arthritis and The Myocardial Ischaemia National Audit Project

    Audrey SL Low1, Deborah P. Symmons2,3, Mark Lunt2, Louise K. Mercer2, Christopher Gale4,5, Kath Watson6, British Society for Rheumatology Biologics Registers (BSRBR) Control Centre Consortium1, William G. Dixon7, Kimme L. Hyrich8 and On behalf of the BSRBR9, 1Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 2Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom, 3Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 4Division of Epidemiology, Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, United Kingdom, 5Department of Cardiology,York Teaching Hospital NHS Foundation Trust, York, United Kingdom, 6Arthritis Research UK Epidemiology Unit, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 7The University of Manchester, Manchester, United Kingdom, 8Arthritis Research UK Epidemiology Unit, Manchester Academic Health Sciences Centre, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 9British Society for Rheumatology, London, United Kingdom

    Background/Purpose: The BSRBR-RA was established to compare the long term safety of anti tumour necrosis factor (TNFi) drugs with non-biologic drugs (nbDMARD) in subjects with…
  • Abstract Number: 1042 • 2013 ACR/ARHP Annual Meeting

    Comparison Of Medication Usage Following Myocardial Infarction In Patients With Autoimmune Rheumatic Disease Versus Controls

    Sharon Van Doornum1, Mark Tacey1, Megan Bohensky1, Caroline Brand2, Vijaya Sundararajan3 and Ian Wicks4, 1Melbourne EpiCentre, The University of Melbourne, Melbourne, Australia, 2Melbourne EpiCentre, The Royal Melbourne Hospital, Melbourne, Australia, 3Medicine, University of Melbourne, Melbourne, Australia, 4Rheumatology Unit, Royal Melbourne Hospital, Melbourne, Australia

    Background/Purpose: We have previously demonstrated that RA patients have higher post-myocardial infarction (MI) case fatality than controls [1] and that treatment with secondary prevention medications…
  • « Previous Page
  • 1
  • …
  • 2178
  • 2179
  • 2180
  • 2181
  • 2182
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology